VantAI rewrites the rules of drug discovery by making protein interactions programmable with Foundation ML, breakthrough data generation technology ready to scale, and an unmatched track record including $5B in deals with Bristol Myers Squibb, Johnson & Johnson, Sanofi and other leaders.
